Pluripotent stem cell-derived natural killer cells for cancer therapy
To access this article, please choose from the options below
Supported by NIH/NHLBI R01 HL77923.
PII: S1931-5244(10)00156-8
doi:10.1016/j.trsl.2010.07.008
© 2010 Mosby, Inc. All rights reserved.
